Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.89
+0.03 (0.44%)
At close: Jan 17, 2025, 4:00 PM
6.87
-0.02 (-0.29%)
After-hours: Jan 17, 2025, 5:32 PM EST
Accolade Market Cap
Accolade has a market cap or net worth of $562.12 million as of January 17, 2025. Its market cap has decreased by -34.63% in one year.
Market Cap
562.12M
Enterprise Value
574.54M
1-Year Change
-34.63%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $562.12M, a decrease of -59.97%. That is a compound annual growth rate of -18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 562.12M | 104.08% |
| Dec 31, 2024 | 275.44M | -69.92% |
| Dec 29, 2023 | 915.55M | 63.37% |
| Dec 30, 2022 | 560.40M | -68.11% |
| Dec 31, 2021 | 1.76B | -26.60% |
| Dec 31, 2020 | 2.39B | 70.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |